Vaccine: X
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 42.4% | 0.704 | Q1 | 73.1% |
| 2024 | 2.2 | Q3 | 44.6% | 0.686 | Q1 | 72.9% |
| 2023 | 2.7 | Q3 | 53.0% | 0.682 | Q1 | 74.9% |
| 2022 | 3.8 | 60.8% | 1.509 | Q1 | 93.1% | |
| 2021 | — | 33.1% | 1.129 | Q1 | 88.9% | |
| 2020 | — | — | 1.316 | Q1 | 90.5% | |
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2590-1362
region
Western Europe
coverage
2019-2026